Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmacy v. PBM lawsuit

Executive Summary

Pharmacy Freedom Fund lawsuit against pharmacy benefit managers delayed until early 2003 while organization decides on optimal legal strategy. Group is likely to file two suits: (1) permanent injunction against the AdvancePCS, Express Scripts and Merck-Medco joint venture RxHub; and (2) multi-plaintiff private action or class action against PBMs on grounds of "restraint of trade" and price-fixing. Chicago law offices of Fewkes, Wentz & Strayer had expected to file a suit this fall (1"The Pink Sheet" June 24, p. 23)...

You may also be interested in...



Pharmacy Class Action Lawsuit Will Target PBMs; Case Expected In Fall

Pharmacy benefit management companies are preparing to defend pricing practices in response to a class action suit planned by independent pharmacies

Sanofi Tries To Stop Lantus Biosimilar By Getting Supreme Court To Review PTAB, Again

Sanofi seeks to delay decision clearing path for Mylan's Lantus biosimilar; says it should be able to get rehearing based on Federal Circuit's ruling that PTAB judges were not constitutionally appointed.

Sanofi Improperly Listed Lantus Patent In FDA's Orange Book, Appeals Court Finds

First Circuit reverses dismissal of direct purchasers' suit alleging improper listing of patent on device drive mechanism delayed competition; district court to decide if this constitutes antitrust violation.

UsernamePublicRestriction

Register

PS040628

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel